Resources
Welcome. Our Resources page contains a wide range of information about the State of Michigan's activities related to the prevention, control and surveillance of the human immunodeficiency virus (commonly called HIV) and sexually transmitted infections (also known as STIs).
Major topic categories are listed in alphabetical order. Simply click on a heading to see the resources associated with that topic.
Accreditation
The Michigan Local Public Health Accreditation Program seeks to ensure and enhance the quality of local public health in Michigan by identifying and promoting the implementation of public health standards for local public health departments, and evaluating and accrediting local health departments on their ability to meet these standards.
For technical assistance with the accreditation program, or to propose modifications to the accreditation program indicators, contact Irda Kape of MDHHS at 517-241-4531 (e-mail: kapei@michigan.gov)
Adolescents
Leichliter JS, Copen C, Dittus PJ. Confidentiality Issues and Use of Sexually Transmitted Disease Services Among Sexually Experienced Persons Aged 15-25 Years - United States, 2013-2015. MMWR Morb Mortal Wkly Rep. 2017;66(9): 237-241. DOI: http://dx.doi.org/10.15585/mmwr.mm6609a1.
Sexually Transmitted Diseases (STDs) - Life Stages and Populations: Adolescents and Young Adults
(Centers for Disease Control and Prevention)
While STIs affect individuals of all ages, they take a particularly heavy toll on young people. CDC estimates that youth ages 15-24 make up just over one quarter of the sexually active population, but account for half of the 20 million new sexually transmitted infections that occur in the United States each year. The resources on this page provide information about the impact of STIs on youth, as well as resources for reaching this population.
Talk with Your Teen About Preventing STDs
(U.S. Department of Health & Human Services)
Aging
HIV and Cognitive Dysfunction Toolkit for Professionals
The HIV and Cognitive Dysfunction Toolkit for professionals includes resources from the Alzheimer's Association and Michigan Alzheimer's Disease Resource Center to provide information on Alzheimer's disease and other dementias, screening for cognitive disorders, and information for patients on how to get additional support and assistance.
For more information on Alzheimer's research for PLWH or any questions, please contact:
Kate Pierce, LMSW (she, her, hers)
Program Director
Alzheimer's Association Michigan Chapter
kpierce@alz.org
248-996-1036
https://www.alz.org/gmc
Food, Friends, and Connections Program
The Food, Friends and Connections program aims to provide community, home-delivered meals, limited transportation, and companionship to adults age 60+ living with HIV in Clinton, Eaton, and Ingham counties.
For more information, please see:
Food, Friends, and Connections Program Flyer
For additional questions, please contact:
Tammy Lemmer (she/hers)
Community Relations Director
Tri-County Office on Aging (Lansing Location)
LemmerT@tcoa.org
517-887-1382
Consumer Brochures
PrEP (Pre-Exposure Prophylaxis)
- English (Michigan Department of Health and Human Services, 2019)
What You Need to Know About HIV Testing
- English (Michigan Department of Health and Human Services, 2015)
- Spanish (Michigan Department of Community Health, 2010)
- Arabic (Michigan Department of Community Health, 2010)
Learn the Facts About HIV and STIs
- English (Michigan Department of Health and Human Services, 2021)
HIV and Syphilis Testing During Pregnancy
- English (Michigan Department of Health and Human Services, 2020)
Data Security and Confidentiality
Retention Guidelines for HIV Medical Records
(Michigan Department of Community Health, 2006)
The purpose of this document is to provide HIV/AIDS counselors and administrators with guidelines for maintaining HIV/AIDS medical records. This document should only be considered an interpretation of Michigan law and is not a substitute for your agency's own legal research.
Health Insurance Portability and Accountability Act of 1996 (HIPAA): Health Information Privacy
(U.S. Department of Health & Human Services)
Find guidance and information about the HIPAA Privacy Rule, including what information is protected and how health information can be used and disclosed. Per Section 164.512(b) of the HIPAA legislation, the reporting of communicable diseases and infections (including HIV and STIs) to the local or state health department or immunizations to the Michigan Childhood Immunization Registry are exempt because they are mandated within the Michigan Public Health Code and are used for surveillance and prevention of communicable diseases and infections.
Michigan Disease Surveillance System (MDSS) HIV and AIDS Confidentiality Policy
(Michigan Department of Community Health, 2010)
MDSS, a Web-based communicable disease reporting system developed for the state of Michigan, provides an alternative method of reporting HIV or AIDS infection to the health department that will enhance the timeliness and quality of the data. The purpose of this policy is to ensure the confidentiality of HIV or AIDS information when using MDSS as a reporting tool.
MDSS Security and Confidentiality Training & Guidelines
(Michigan Department of Community Health, rev. 2011)
All MDDS users who have HIV Program access should have policies and procedures in place to protect the security and confidentiality of HIV data. In addition, users should complete a security and confidentiality training on an annual basis. This training, along with the MDSS HIV and AIDS Confidentiality Policy, provide the recommended guidelines for the protection of HIV data within MDSS.
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP) Program Collaboration and Service Integration (PCSI) Data Security and Confidentiality Guidelines
(Centers for Disease Control and Prevention)
One of NCHHSTP's goals is to strengthen collaborative work across disease areas and integrate services that are provided by state and local programs for prevention of HIV/AIDS, viral hepatitis, other STIs, and tuberculosis. A major barrier to achieving this goal is the lack of standardized data security and confidentiality procedures acts as a major barrier to achieving this goal. Adoption of common practices for securing and protecting data can provide a critical foundation and be increasingly important for ensuring the appropriate sharing and use of data as programs begin to modify policies and increasingly use data for public health action.
- NCHHSTP Data Security and Confidentiality Guidelines for HIV, Viral Hepatitis, Sexually Transmitted Disease, and Tuberculosis Programs: Standards to Facilitate Sharing and Use of Surveillance Data for Public Health Action
(Centers for Disease Control and Prevention, 2011)
This document recommends standards for all NCHHSTP programs that, when adopted, will facilitate the secure collection, storage, and use of data while maintaining confidentiality.
Educational Resources
Midwest AIDS Training + Education Center (MATEC)
MATEC sites offer workshops and skills-building programs for clinicians working in HIV care and prevention. The programs range in length from one hour to several days and focus on a broad range of topics, from Cultural Competence and HIV Care to Managing Anti-Retroviral Drug Failure.
Michigan HIV Consultation Program (for healthcare providers)
The Michigan HIV Consultation Program is set up to answer questions from Michigan healthcare professionals regarding: HIV disease management; HIV drug-drug interactions; HIV occupational and non-occupational post-exposure prophylaxis (PEP and nPEP); HIV pre-exposure prophylaxis (PrEP); and perinatal HIV treatment. Providers with urgent questions can use the 24-hour consultation line at 313-575-0332.
Michigan HIV/STI Hotline (for consumers)
Consumers with questions related to HIV and STIs are encouraged to call the toll-free Michigan HIV/STI Hotline at 800-872-2437 (Monday-Friday, 9:00 a.m.-5:00 p.m.)
AIDS Education and Training Center (AETC)
AETC is the training arm of the Ryan White HIV/AIDS Program. It is a national network of HIV experts who provide locally based, tailored education, clinical consultation, and technical assistance to healthcare professionals and healthcare organizations to integrate high-quality, comprehensive care for those living with, or affected by, HIV.
- National HIV Curriculum
Developed by the AETC Network, the National HIV Curriculum offers free online continuing education for novice-to-expert health professionals, students, and faculty, providing access to ongoing, up-to-date information needed to meet the core competency knowledge for prevention, screening, diagnosis, and ongoing treatment and care of HIV.
AIDSinfo offers access to the latest, federally approved HIV/AIDS medical practice guidelines, HIV treatment and prevention clinical trials, and other research information for healthcare providers, researchers, people affected by HIV/AIDS, and the general public. A service of the U.S. Department of Health and Human Services, the web-based resource is maintained by the National Library of Medicine.
HIV/AIDS Bureau (HAB)
HAB, part of the U.S. Department of Health and Human Services, Health Resources and Services Administration, administers the Ryan White HIV/AIDS Program, which is the largest federal program focused exclusively on HIV/AIDS care. The Ryan White program is for people living with, or affected by, HIV/AIDS who do not have sufficient healthcare coverage or financial resources for coping with the disease.
TARGET (Technical Assistance Resources, Guidance, Education & Training) Center
The TARGET Center website is the central source of tools, webcasts, trainings, and other technical assistance and training resources for the Ryan White HIV/AIDS Program. The site's intended audience includes Ryan White fund recipients and providers, planning bodies, and staff of the HIV/AIDS Bureau, but also extends to consumers in search of services, various health and human service agencies, and the general public.
- ACE TA (Access, Care & Engagement Technical Assistance) Center
The ACE TA Center helps Ryan White HIV/AIDS Program recipients and subrecipients support their clients, especially people of color, in navigating the healthcare environment through enrollment in health coverage and improved health literacy. The ACE TA Center provides practical tools and resources that are informed by culturally competent best practices and designed to support engagement, education, enrollment, and renewal activities.
HIV/AIDS & STDs (Centers for Disease Control and Prevention)
The HIV/AIDS & STDs web portal provides access to fact sheets, brochures, and other publications; treatment information and guidelines; and other resources for both consumers and healthcare professionals.
Ending the HIV Epidemic Initiative
The Michigan Department of Health and Human Services and the Detroit Health Department are actively working together in collaboration with other public health partners and community members to develop and implement a plan for Wayne County as part of the national Ending the HIV Epidemic (EHE) initiative.
Michigan's EHE initiative, which officially kicked off in October 2019, is one of 48 initiatives launched throughout the United States. For more information, visit the Michigan EHE Initiative home page.
General Information
HIV and STIs: The Basics
(Michigan Department of Health and Human Services)
This webpage provides an introduction to HIV, viral hepatitis, and STIs and includes links to a variety of tools and guidelines for consumers and healthcare providers alike.
Michigan HIV and STI Law Updates FAQ
(Michigan Department of Health and Human Services, 2019)
This is a summary document to assist in understanding the updates to the HIV and STI laws that occurred in December 2018, and the way they may influence the testing and treating HIV and other STIs.
Infographic: Bloodborne Pathogen Transmission Risk Among First Responders
(Michigan Department of Health and Human Services, 2018)
Infographic: Needlestick Injury is Risky Business
(Michigan Department of Health and Human Services, 2018)
Epidemiologic Profiles of HIV in Michigan
(Michigan Department of Health and Human Services, 2018)
This biennial publication provides epidemiological data and analysis of the HIV epidemic in Michigan. The 2018 edition includes information on HIV prevalence, trends in new HIV diagnoses, estimates of HIV incidence rates, HIV care and services, HIV prevention, molecular HIV surveillance, behavioral and clinical outcomes, sexually transmitted infections (STIs) and STI/HIV co-infections, Hepatitis C (HCV) and HCV/HIV co-infection, and HIV infection among tuberculosis cases.
Division of HIV and STD Programs Strategic Plan
(Michigan Department of Health and Human Services, 2019)
Grants/Contracts/Fiscal
There are no open RFPs at this time.
Michigan HIV Care Sub-Recipient Agencies
MDHHS EGrAMS Portal (Electronic Grants Administration & Management System)
Please Note: EGrAMS is password protected, and only EGrAMS authorized users are granted access.
MDHHS Fiscal Year 2021 Ryan White Reporting Tool Update Webinar
New Fiscal Year 2020 Ryan White Reporting Requirements
- Including FY19 Ryan White Auditing Update
- Michigan Ryan White Accounting Technical Assistance
Administrative Costs Reporting
Program Income Reporting
- Part B Reporting Form
- Part D Reporting Form
Ryan White Policy Guidance
- 14-01: Eligibility and Recertification
- 14-02: Administration Expense Cap
- 20-03: Incentives
- Federal Poverty Guidelines
- Conflict of Interest Policy
MDHHS Division of HIV and STI Programs Incentives Toolkit Webinar
This recorded webinar provides guidance and tools to help your agency understand the use of incentives.
MDHHS Division of HIV and STI Programs Incentives Toolkit PowerPoint
- HIV-STI Client Acknowledgement Form
- MDHHS Ryan White Guidance #20-03
- Ryan White Food Guidance Document
- Store Card Directory
- Store Card Inventory Tracking Form
- Store Cards and Incentives Policy Template
Michigan HIV Care & Prevention Section Technical Assistance Form
This form can be used by Michigan HIV case managers and clinical providers to request technical assistance related to prevention, the Ryan White Program, care coordination, and various administrative needs. HIV Care & Prevention staff will contact the requestor within three business days of receiving the completed form.
Guidance
- PEP (Post-Exposure Prophylaxis) and nPEP (Non-Occupational Post-Exposure Prophylaxis)
- Non-Occupational Post-Exposure Prophylaxis (nPEP) Guidance
(Michigan Department of Health and Human Services, rev. June 2019)- Excerpts from the nPEP Guidance
(Michigan Department of Health and Human Services, rev. June 2019)
- Excerpts from the nPEP Guidance
- Updated Guidelines for Antiretroviral Postexposure Prophylaxis After Sexual, Injection Drug Use, or Other Nonoccupational Exposure to HIV - United States, 2016
(Centers for Disease Control and Prevention, 2016) - Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to Human Immunodeficiency Virus and Recommendations for Postexposure Prophylaxis
(National Center for Emerging and Zoonotic Infectious Diseases, 2013)
- Non-Occupational Post-Exposure Prophylaxis (nPEP) Guidance
- PrEP (Pre-Exposure Prophylaxis)
- Pre-Exposure Prophylaxis (PrEP) Provider Toolkit
(Michigan Department of Health and Human Services, 2017) - Preexposure Prophylaxis for the Prevention of HIV Infection in the United States, 2017 Update - A Clinical Practice Guideline
(Centers for Disease Control and Prevention, 2018)- Preexposure Prophylaxis for the Prevention of HIV Infection in the United States, 2017 Update - Clinical Providers' Supplement
(Centers for Disease Control and Prevention, 2018)
- Preexposure Prophylaxis for the Prevention of HIV Infection in the United States, 2017 Update - Clinical Providers' Supplement
- Pre-Exposure Prophylaxis (PrEP) Provider Toolkit
HIV/AIDS Clinical Guidelines
(U.S. Department of Health and Human Services)
These federally approved medical practice guidelines for HIV/AIDS are developed and updated by panels of HIV care experts. Following are selected USDHHS guidelines of interest.
- Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents Living with HIV
- Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection
- Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States
- Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents
- Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Exposed and HIV-Infected Children
- Recommendations for HIV Prevention with Adults and Adolescents with HIV in the United States, 2014 (amended December 2016)
- Revised Recommendations for HIV Testing of Adults, Adolescents, and Pregnant Women in Health-Care Settings
- Laboratory Testing for the Diagnosis of HIV Infection, Updated Recommendations
(Note: To be used in conjunction with 2018 Quick Reference Guide: Recommended Laboratory HIV Testing Algorithm for Serum or Plasma Specimens; Technical Update on HIV-1/2 Differentiation Assays; and Technical Update: Use of the Determine HIV 1/2 Ag/Ab Combo Test with Serum or Plasma in the Laboratory Algorithm for HIV Diagnosis.) - Rapid HIV Testing Guidelines for Pharmacies
Guidelines for Testing and Reporting: Perinatal Human Immunodeficiency Virus (HIV), Hepatitis B and Syphilis
(Michigan Department of Health and Human Services, rev. March 2020)
Physicians and other healthcare professionals providing medical treatment to pregnant women are required, at the time of initial prenatal screening and examination, to test for HIV, hepatitis B, and syphilis, unless the woman refuses to be tested or the provider deems the tests are medically inadvisable. These guidelines are for healthcare professionals working in prenatal care, labor and delivery, and emergency services.
Primary Care Guidance for Persons With Human Immunodeficiency Virus: 2020 Update
(HIV Medicine Association of the Infectious Diseases Society of America, 2020)
This evidence-based guidance for the primary care of persons living with human immunodeficiency virus (HIV) is intended for use by healthcare providers who care for persons living with HIV. Every 12 to 18 months following publication, IDSA reviews its guidelines to determine whether an update is required. This guidance was published in November of 2020 as an update to the 2013 guidelines.
Recommendations for Conducting Integrated Partner Services for HIV/STI Prevention
(Michigan Department of Community Health, 2011)
These recommendations were developed to articulate standards for providing partner services in Michigan for HIV, early syphilis, gonorrhea, and chlamydia and guide and inform the provision of such services.
2021 Sexually Transmitted Infections Treatment Guidelines
(Centers for Disease Control and Prevention)
Physicians and other health care providers can use these guidelines to assist in prevention and treatment of STIs. The new guidelines include notable updates from the previous 2015 guidance, including:
- updated treatment recommendations for chlamydia, trichomoniasis, and pelvic inflammatory disease;
- updated treatment recommendations for uncomplicated gonorrhea in neonates, children, and other specific clinical situations (e.g., proctitis, epididymitis, sexual assault), which builds on broader treatment changes published in Morbidity and Mortality Weekly Report;
- information on FDA-cleared diagnostic tests for Mycoplasma genitalium and rectal and pharyngeal chlamydia and gonorrhea;
- expanded risk factors for syphilis testing among pregnant patients;
- recommended two-step serologic testing for diagnosing genital herpes simplex virus;
- harmonized recommendations for human papillomavirus vaccination with the Advisory Committee on Immunization Practices; and
- recommended universal hepatitis C testing in alignment with CDC's 2020 hepatitis C testing recommendations.
STD Program Management & Evaluation Tools
(Centers for Disease Control and Prevention)
Housing
Housing Opportunities for Persons With AIDS (HOPWA)
(U.S. Department of Housing and Urban Development)
The HOPWA program is the only federal program dedicated to the housing needs of people living with HIV/AIDS. Under the HOPWA program, HUD makes grants to local communities, states, and nonprofit organizations for projects that benefit low-income persons living with HIV/AIDS and their families. There are currently six HOPWA-funded service agencies in our state.
- HOPWA Service Agencies in Michigan
Roster of HOPWA service agencies in Michigan; includes the geographic area(s) served by the agency and contact information for both the agency and its primary HOPWA staff person.
Link-Up Michigan
Are you:
- HIV positive?
- a Michigan resident?
- not currently receiving HIV medical care?
If you answered "yes" to all three questions, you are eligible for the Link-Up Michigan program. The mission of Link-Up Michigan is to help ensure that every HIV-positive person in our state has the medical and social support he or she needs to achieve viral suppression and live a happy and healthy life. The program's services are free, confidential and voluntary.
Link-Up Michigan connects Michigan residents who are HIV-positive but are not currently accessing HIV/AIDS medical care to both medical and non-medical services. The Link-Up program provides each individual with short-term, intensive support through referrals to existing community support programs. It also helps eligible HIV-positive individuals engage with HIV medical providers.
- Link-Up is already providing services to clients throughout Michigan. See how the program is working in two Michigan communities.
- Link-Up Michigan is a Data to Care strategy. Read more about Data to Care strategies.
- Michigan residents: Link-Up Michigan
- Residents of metro Detroit: Link-Up Detroit
Medical Monitoring Project (MMP)
The Medical Monitoring Project (MMP) is a public health initiative designed to monitor the behaviors, medical care, and health status of people who are living with HIV. It is supported by several government agencies and conducted by state and local health departments, along with the Centers for Disease Control and Prevention. By collecting locally and nationally representative behavioral and medical record data from people living with HIV, MMP helps researchers determine:
- How many people living with HIV are receiving medical care for HIV?
- How easy is it for people living with HIV to access medical care, prevention, and support services?
- What are the met and unmet needs of people living with HIV?
- How is treatment affecting people living with HIV?
Michigan has participated in MMP since 2005. To learn more about the Michigan MMP and how it works, visit: Michigan Medical Monitoring Project.
National HIV Behavioral Surveillance (NHBS)
National HIV Behavioral Surveillance (NHBS) is a multisite project funded by the Centers for Disease Control and Prevention. NHBS was established to identify behaviors that place individuals at-risk for contracting HIV/AIDS. NHBS operates through activities designed to monitor HIV risk behaviors in order to assist in prevention education, service initiatives, and allocation of prevention resources. The project occurs in multiple cycles, with each year targeting one of three high-risk populations: men who have sex with men; intravenous drug users; and heterosexuals at risk for contracting HIV.
Michigan has participated in numerous HIV surveillance activities and interview studies since 1986. Michigan NHBS activities include: 1) a core questionnaire that addresses demographics, sexual history, alcohol and drug use history, HIV testing history, incarceration history, and prevention activities; 2) a local questionnaire that was developed with input from service providers, community leaders, and individuals living in metro Detroit areas; and 3) HIV testing. All activities are anonymous.
To learn more about NHBS in Michigan, how it works, and what it has found, visit: Michigan National HIV Behavioral Surveillance.
Partner Services (including APHIRM)
The mission of the HIV/STI Partner Services program is to help reduce the transmission of HIV and sexually transmitted infections (STIs) among sex and needle-sharing partners of persons diagnosed as having HIV and/or STIs, such as syphilis, gonorrhea, and chlamydia.
Through Partner Services, persons living with HIV and/or diagnosed with a STIs are counseled about their disease state by their provider or certified Partner Services staff, and given risk reduction information, treatment, and/or referral to other care services as appropriate. Persons living with HIV and/or diagnosed with a STI also are counseled on the importance of notifying their sex and needle-sharing partners and told that assistance is available to help them do that, if needed.
Partner Services depends upon the voluntary cooperation of persons living with HIV and/or diagnosed with a STI to work with certified staff or other medical providers to share information about their partners so that those individuals may be confidentially notified of their potential exposure and provided risk-reduction counseling and referrals to treatment and other support services.
The Partner Services Patient Guide, a brochure written for patients/clients, explains the HIV/STI Partner Services program.
- Partner Services Delivery Through Local Health Departments
- Partner Services Delivery Through Community-Based Organizations
- DCH-1221: Confidential Request Form for Local Health Department Assistance with Partner Services (rev. July 2015)
(Healthcare providers can use this form to refer persons diagnosed as having HIV/AIDS or an at-risk sex/needle-sharing and/or cluster/network partner to a local health department for assistance with HIV Prevention Partner Services.)
- Recommendations for Conducting Integrated Partner Services for HIV/STI Prevention (rev. August 2011)
These recommendations were developed to articulate standards for providing partner services in Michigan for HIV, early syphilis, gonorrhea, and chlamydia and guide and inform the provision of such services. - Telephone Interview Protocol for HIV Partner Services
- Michigan Internet Partner Services Guidance
APHIRM is a cloud-based data system created by Luther Consulting under contract with the Centers for Disease Control and Prevention (CDC) to capture data from HIV testing and partner services outcomes. APHIRM is funded by CDC funding opportunity announcement PS18-1802. Local public health workers tasked with conducting partner services use this system to document client follow-up and log client responses to questions about medical care and risk behaviors. APHIRM data is de-identified prior to being uploaded to CDC through Evaluation Web for reporting purposes.
Partners - Michigan
Michigan Department of Health and Human Services Partners
- MDHHS Bureau of Laboratories
- MDHHS Communicable Diseases
- MDHHS Division of Child and Adolescent Health
- MDHHS Family Planning Program
- MDHHS Health Disparities Reduction and Minority Health Section
- MDHHS Michigan Dental Program
- MDHHS Tobacco Section
- MDHHS Viral Hepatitis Surveillance and Prevention Unit
Community Partners
Partners - National
Federal Government Partners
Organizational Partners
- American Sexual Health Association
- NASTAD (formerly the National Alliance of State and Territorial AIDS Directors)
- National Coalition of STD Directors
- National Prevention Information Network
- New York City STD/HIV Prevention Training Center
Perinatal HIV/STI
For information on perinatal HIV and STIs including screening guidance and consultation support, please visit: Perinatal HIV and STIs.
PrEP and nPEP
PrEP (Pre-Exposure Prophylaxis) is a once-a-day HIV-prevention pill that can be taken by people who do not have HIV now, but who are at high risk of getting it.
The PrEP pill contains two medicines that are used in combination with other medicines to treat HIV. When someone who has been taking the pill is exposed to HIV through sex or injection drug use, the medicines can keep the virus from establishing a permanent infection.
When taken once a day as directed, PrEP has been shown to reduce the risk of HIV infection in high-risk people by up to 92 percent. But, it loses much of its effectiveness if it is not taken consistently.
- Directory of Michigan PrEP Providers
- Michigan PrEP Payment Guide
- PrEP Provider Toolkit
- PrEP Assessment Tools
- Resources and printable materials for consumers and providers from the CDC
- Preexposure Prophylaxis for the Prevention of HIV Infection in the United States, 2017 Update - A Clinical Practice Guideline (U.S. Public Health Service, March 2018)
- Clinical Providers' Supplement (U.S. Public Health Service, March 2018)
- Clinical Providers' Supplement
-
Michigan HIV Consultation Program (provides healthcare providers with answers about HIV-related issues)
- Non-urgent questions (providers only): Visit the HIV Consultation Program page, choose "Request a Consult," and submit your question(s) online. You will receive an answer within 48 hours.
- Urgent questions (providers only): Call the 24-hour consultation line at 313-575-0332.
- Please Note: Consumers with questions related to HIV and STIs are encouraged to call the Michigan HIV/STI Hotline at 1-800-872-2437 (Monday-Friday, 9:00 a.m.-5:00 p.m.)
- Clinician Consultation Center and Hotline for PrEP (University of California Department of Family and Community Medicine)
- PrEPcost.org (If you are considering PrEP for HIV prevention, the PrEPcost.org website can help you choose the best marketplace health plan for you.)
nPEP (Non-Occupational Post-Exposure Prophylaxis) is a preventive treatment that can reduce the chance that a person who is exposed to HIV will become HIV-positive.
The nPEP treatment involves two to three antiretroviral medicines that work together to prevent HIV from making copies of itself and spreading through the body. To be effective, the medicines must be started as soon as possible - but not more than 72 hours (3 days) after - possible exposure to the virus. They also must be taken on schedule for 28 days.
nPEP medicines can reduce the risk of becoming HIV-positive. But, they are not always effective. Taking them does not guarantee that someone exposed to HIV will not become infected with HIV.
- MDHHS Guidance for Administration of HIV nPEP (Non-Occupational Post-Exposure Prophylaxis) (rev. June 2019)
- MDHHS nPEP Guidance excerpts (rev. June 2019)
Program Planning
Quitting Tobacco
People living with HIV (PLWH for short) are much more apt to smoke than are their peers. In fact, smoking prevalence is more than twice as high among PLWH in Michigan than among the general population (50 percent vs. 21 percent).
The advances in HIV testing and treatment, coupled with the relatively large number of PLWH who smoke, mean that today, individuals with HIV who smoke are much more likely to die from tobacco-related illness (such as lung cancer, heart disease, or stroke) than from complications of HIV Stage 3.
It's ironic. People now survive HIV, only to die from a smoking-related disease.
Because so many PLWH in Michigan smoke, and because smoking is such a serious threat to health, the MDHHS Tobacco Section and the MDHHS HIV Care & Prevention Section have joined forces on the Tobacco Use Reduction in People Living with HIV project.
As part of the project, MDHHS is working with HIV/AIDS service organizations (ASOs) throughout the state to accomplish three goals:
- improve health outcomes in PLWHA (long-term goal);
- increase the number of tobacco quit attempts (mid-term goal); and
- increase the use of tobacco treatment clinical practice guidelines (short-term goal).
Visit the dedicated MDHHS Tobacco Use Reduction in People Living with HIV Project pages to learn more.
Ryan White HIV/AIDS Program (including CAREWare)
The Ryan White HIV/AIDS Program provides a comprehensive system of care that includes medical care and support services for people living with HIV who are uninsured or underinsured. The program works with cities, states, and local community-based organizations to provide HIV care and treatment services to more than half a million people each year. It is administered by the U.S. Department of Health and Human Services, Health Resources and Services Administration, HIV/AIDS Bureau.
Michigan (MDHHS)
- MDHHS Ryan White Program Guidance #14-01: Eligibility and Recertification (rev. April 2018)
- MDHHS-5422: Declaration of Residency/ No Income or Support/ Insurance Ineligibility (rev. December 2017)
- MDHHS-5422: Declaration of Residency/ No Income or Support/ Insurance Ineligibility
- MDHHS Ryan White Program Guidance #14-02: Administration Expense Cap (rev. September 2014)
- MDHHS Ryan White Program Guidance #20-03: Incentives (rev. November 2020)
Federal (HRSA)
- Health Resources and Services Administration, HIV/AIDS Bureau home page
- Ryan White Policy Notices and Program Letters
Michigan (MDHHS)
- MDHHS Ryan White Program Service Standards (rev. May 2020)
- Appendix A (rev. August 2020)
- Appendix B (rev. December 2019)
- Appendix A
- MDHHS Guidelines for Testing and Reporting: Perinatal Human Immunodeficiency Virus (HIV), Hepatitis B and Syphilis (rev. March 2020)
- MDHHS Michigan HIV Case Management Standardized Tools
- Biopsychosocial Assessment Tool
- Acuity Scale Tool
- Care/Service Plan Tool
- Health Insurance Premium Cost Sharing Assistance Procedure
- MDHHS HIPCA, DMR, MIDAP, PA, Medicaid, Gap Insurance Education Training -This recording includes updates from the Continuum of Care Unit (CoC), Michigan Drug Assistance Program (MIDAP), Insurance Assistance Program (IAP) and Script Guide Rx. We take a deeper dive into the policy and procedures for HIPCA and MIDAP along with updates to the Direct Member Reimbursement Process.
Federal (HRSA)
Michigan (MDHHS)
- Michigan HIV Resource Inventory
- Introduction and Glossary of Terms
- Inventory of Resources (rev. Dec. 19, 2017)
- Introduction and Glossary of Terms
- MDHHS Health Insurance Premium Cost Sharing Assistance (HIPCA) Needs Requests Form (June 2020)
- MDHHS HIV Care & Prevention Section Technical Assistance Request Form (rev. February 2021)
Michigan HIV case managers and clinical providers can use this form to request technical assistance related to prevention, the Ryan White Program, care coordination, and various administrative needs. HIV Care & Prevention staff will contact the requestor within three business days of receiving the completed form. - DHS-424: Client Benefits Evaluation Form (rev. February 2016)
Case managers can use this form to gather information that will help determine a client's possible eligibility for welfare entitlement benefits (e.g., Social Security Disability Insurance, Medicaid, Food Assistance Program), other government benefits (e.g., Michigan Drug Assistance Program, Insurance Assistance Program), and other community resources and/or benefits.
Federal (HRSA)
- Annual Ryan White HIV/AIDS Program Services Report (RSR)
- Ryan White HIV/AIDS Program Part B Manual (rev. 2015)
- TARGET Center (Technical Assistance Resources, Guidance, Education & Training for the Ryan White community)
Michigan (MDHHS)
- MDHHS Integrated Ryan White Parts B and D Quality Management Plan (2020-2021)
- MDHHS Summary of Performance Measures
Federal (HRSA)
- HRSA HAB Performance Measures
- HRSA Policy Clarification Notice (PCN) #15-02: Clinical Quality Management
- HRSA HAB CAREWare: Performance Measures Module
- HRSA Ryan White HIV/AIDS Program Center for Quality Improvement and Innovation (CQII)
Ryan White HIV/AIDS Program CAREWare is a free, electronic health and social support services information system for Ryan White HIV/AIDS Program grant recipients and their providers. It was developed by HRSA's HIV/AIDS Bureau and first released in 2000, and it is used to report year-end, Ryan White HIV/AIDS Services Report (RSR) client-level data and to monitor quality of care on a regular basis. CAREWare contains customizable modules for tracking demographics, services, medications, laboratory test results, immunization history, diagnoses (updated with ICD-10 codes), and referrals to outside agencies.
Hours: 8:00 a.m. - 5:00 p.m., Monday - Friday
Phone: 517-335-7718
Email: MDHHS-DHSP-TAandData-Requests@michigan.gov
Introducing CAREWare Version 6
CAREWare has been updated and has a new user interface that runs in any internet browser except for Internet Explorer. Version 6 includes the same functionality as Version 5 with some additional features.
- Downloading and Installing CAREWare
- Logging in for the first time:
- Go to "My Settings."
- Change your password to something you will remember.
- Update your contact information with your current phone number and email address.
- Update your security questions.
- CAREWare 6 User Guide
- CAREWare 6 Data to Care Quick Guide
- HRSA HAB CAREWare Home Page
- MDHHS Ryan White Parts B and D CAREWare Service Categories and Sub-Services (Appendix A of MDHHS Ryan White Program Standards of Care)
- MiLogin- Request Gain CW Access
- MDHHS-5623: Michigan CAREWare New User Request Form (rev. August 2020)
(Please Note: This form is to be completed by agency staff who need CAREWare system access. This form requires agency supervisor approval and should be scanned and emailed to MDHHS-DHSP-TAandData-Requests@michigan.gov for processing. Questions may be directed to staff at 517-335-7718.)
- Any password resets or MiLogin related issues will have to contact the State of Michigan's DTMB MiLogin Team at 517-241-7681 or 877-932-6424. Questions related to CAREWare 6 can be directed to staff at MDHHS-DHSP-TAandData-Requests@michigan.gov or 517-335-7718.
Sexually Transmitted Infections (STIs)
STI Case Reporting and Data Staff
The Disease Intervention Specialists (DIS) that oversee STI case reporting and data functions are part of the Field Services and STI Prevention Section within the MDHHS Division of HIV and STI Programs and are located throughout Michigan. Their responsibilities are divided by geographical coverage areas of the state.
- More information about DIS in Michigan
- DIS Staff Coverage Map (staff assignments by geographical area of coverage)
(Please Note: Contact information for individual team members is available in the Directory of MDHHS HIV and STI Program Staffers on our Contact Us webpage.)
STI Clinical Service Locations
- STI Clinical Service Locations This list provides information on local health departments that offer STI clinical services, as well as organizations that offer STI specialty services.
Other Resources
- Community Approaches to Reducing Sexually Transmitted Diseases. CDC guidance on using community engagement methods and partnerships to build local STI prevention and control capacity.
- CDC Recommendations for Providing Quality STD Clinical Services
STI Case Reporting
- Reporting STIs Electronically in the Michigan Disease Surveillance System (MDSS) (rev. February 2021)
- Disseminated Gonococcal Infection Case Report Form
Local health departments should complete this form when following up on a reported case of Disseminated Gonococcal Infection (DGI) in MDSS. Please update the form with available information from the provider and patient. Attach the completed form to the Patient 'Notes' tab in MDSS. Contact Jim Kent at kentj3@michigan.gov with questions about DGI and reporting.
340B STI Drug Reporting Requirements
The 340B STI Drug Reporting Requirements tracking protocol for all 340B STI Drug Covered Entities helps ensure compliance with the 340B Drug Pricing Program. Below are the training materials for the tracking process, the template for the tracking tool, and links to national programs to inform our partners of the compliance standards.
- New 340B STI Medication Ordering Form: Please use this electronic ordering form to order 340B STI medications.
- MDHHS STD 340B Program Resources
- 340B STD Drug Reporting Tool Template
STI 340B Program Webinars
- May 2021 MDHHS Webinar: STI 340B Program Updates
- Full webinar presentation.
This is a recording of the live webinar held on May 20, 2021 (49:06). All MDHHS DHSP grant-funded covered entities are encouraged to view the webinar to hear updates to the program and essential information. - Webinar slides
- Full webinar presentation.
- May 2020 MDHHS Webinar: STD 340B Program Updates
- Full webinar presentation. This is a recording of the live webinar held on May 12, 2020 (1:00:16). All MDHHS DHSP grant-funded covered entities are encouraged to view the webinar to hear updates to the program and essential information.
- Webinar slides
- STD 340B Program Policy and Procedure Manual
- MDHHS STD 340B Centralized Distribution Model Agreement Form
- Full webinar presentation.
- December 2019 MDHHS Webinar: STD 340B Program Updates
- February 2018 MDHHS Training Webinar: New 340B STD Inventory Reporting Process
- Full webinar presentation, including the timeline for implementation, an introduction to the reporting template, and a walk-through of how to use the template to report data. (58:32)
- Webinar slides
- Written summary of Question-and-Answer Session
- Full webinar presentation,
- 340B Drug Pricing Program (Health Resources and Services Administration)
- Apexus 340B Prime Vendor Program (Apexus is the HRSA-designated Prime Vendor for the 340B Drug Pricing Program)
STI/HIV Billing Toolkit
(Michigan Department of Health and Human Services, 2016)
Michigan-based STI/HIV clinics and organizations can use this toolkit to determine whether to bill. It also can be used to set up and maintain a billing infrastructure and to enhance the potential for revenue generation to sustain services.
- Frequently Asked Questions
- March 2018 MDHHS Training Webinar: "Michigan STD/HIV Billing Toolkit Review"
(1:13:17)- MDHHS STD/HIV Billing Toolkit (Michigan Department of Health and Human Services, February 2016)
- Appendix 1: Code Suppression List
- Appendix 2: Cost Benefit Analysis Tool
- Appendix 3: Medicaid Health Plan Key Contacts
- Appendix 4: Sample Superbill
- Appendix 5: Coding Guide
Non-Genital Screening for Chlamydia (CT) and Gonorrhea (GC) in Men Who Have Sex With Men (MSM)
(Michigan Department of Health and Human Services, 2017)
This fact sheet from the MDHHS STI/HIV Prevention Training Center provides information about the reasons for rectal and pharyngeal CT/GC testing, the benefits of nucleic acid amplification tests (NAATs) for screening and diagnosis of CT/GC infections, and a summary of current CT/GC screening recommendations for sexually active, asymptomatic men who have sex with men.
Syphilis Testing Reference Guide
(Michigan Department of Health and Human Services, 2019)
Brief, clinical guidance for syphilis testing.
Update to CDC's Treatment Guidelines for Gonococcal Infection 2020
Centers for Disease Control and Prevention, Dec. 18, 2020 Morbidity and Mortality Weekly Report on updated treatment guidelines for gonococcal infection.
Updated Treatment Recommendations for Gonococcal Infection Health Alert Dec. 21, 2020
Health alert sent on Dec. 21, 2020 regarding the update to treatment recommendations for gonococcal infection.
2021 Sexually Transmitted Infections Treatment Guidelines
(Centers for Disease Control and Prevention)
Physicians and other health care providers can use these guidelines to assist in prevention and treatment of STIs. The new guidelines include notable updates from the previous 2015 guidance, including:
- updated treatment recommendations for chlamydia, trichomoniasis, and pelvic inflammatory disease;
- updated treatment recommendations for uncomplicated gonorrhea in neonates, children, and other specific clinical situations (e.g., proctitis, epididymitis, sexual assault), which builds on broader treatment changes published in Morbidity and Mortality Weekly Report;
- information on FDA-cleared diagnostic tests for Mycoplasma genitalium and rectal and pharyngeal chlamydia and gonorrhea;
- expanded risk factors for syphilis testing among pregnant patients;
- recommended two-step serologic testing for diagnosing genital herpes simplex virus;
- harmonized recommendations for human papillomavirus vaccination with the Advisory Committee on Immunization Practices; and
- recommended universal hepatitis C testing in alignment with CDC's 2020 hepatitis C testing recommendations.
STD Program Management & Evaluation Tools
(Centers for Disease Control and Prevention)
MDHHS STI Outbreak Response Plan
(Michigan Department of Health and Human Services, rev. December 2019)
- 90-Day Retest for Chlamydia and Gonorrhea Clinic Poster (12 by 18 inches)
- 90-Day Retest and STI Partner Referral Awareness Materials Order Form
Chlamydia, Gonorrhea, and Trichomoniasis Expedited Partner Therapy (EPT)
Michigan Public Act 525 of 2014 (MCL 333.5110) authorized the use of expedited partner therapy (EPT) for certain sexually transmitted infections as designated by the state health department. In April 2020, the Michigan Department of Health and Human Services designated chlamydia, gonorrhea, and trichomoniasis as infections for which the use of EPT is appropriate.
- Guidance for Health Care Providers: Expedited Partner Therapy (Michigan Department of Health and Human Services, 2021)
- Expedited Partner Therapy: Information Sheet for Patients and Partners (Michigan Department of Health and Human Services, 2021)
- STI Expedited Partner Therapy Treatment Guidelines (Michigan Department of Health and Human Services, 2021)
- Michigan Pharmacists Association Summary of Expedited Partner Therapy Clinical Guidelines (Michigan Pharmacists Association, 2021)
Antibiotic-Resistant Gonorrhea
(Centers for Disease Control and Prevention)
Antibiotic resistance is the ability of bacteria to resist the effects of the drugs used to treat them. This means the bacteria are no longer killed by a drug that used to kill them before, and the bacteria are then free to keep multiplying. Gonorrhea has developed resistance to nearly all of the antibiotics used for its treatment. We are currently down to one last recommended and effective class of antibiotics (cephalosporins) to treat this common infection. This is an urgent public health threat, because gonorrhea control in the United States largely relies on our ability to successfully treat the infection.
- CDC Website: Antibiotic-Resistant Gonorrhea Information
- Kirkcaldy RD, Harvey A, Papp JR, et al. Neisseria Gonorrhoeae Antimicrobial Susceptibility Surveillance - The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014 MMWR Surveill Summ. 2016;65(No. SS-7):1-19. DOI: http://dx.doi.org/10.15585/mmwr.ss6507a1.
- Antibiotic-Resistant Gonorrhea: It's Time to Take Action
- Health Care Providers: Help Protect Our Last Treatment Option for Gonorrhea
- Antibiotic-Resistant Gonorrhea: Working Together, We Can Stop It
- The State of STIs in Michigan
Syringe Services Program
Sharing needles, syringes, or injection equipment can lead to increased risk of transmission of HIV, hepatitis B and C, or other blood-borne pathogens. Using a needle more than once may increase your risk of infection, blown veins, or abscesses.
A syringe services program is a community-based public health program aimed at providing access to sterile needles and syringes, as well as education about safe disposal of used injection drug equipment and safe injection practices. The program often offers other comprehensive health services, including:
- HIV and hepatitis testing and linkage to care;
- overdose prevention education and treatment;
- substance use disorder treatment programs;
- medical, social and mental health services;
- support groups;
- medical- and non-medical case management; and
- tools to prevent HIV and hepatitis (e.g., counseling, condoms, pre-exposure prophylaxis/PrEP, vaccinations) .
Michigan Syringe Service Program Information is available at: www.michigan.gov/SSP
Michigan Syringe Access Program Resources
- Flyer: Syringe Services Programs
(Michigan Department of Health and Human Services, July 2018)
- Infographic: What Are SSPs?
(Michigan Department of Health and Human Services, July 2018)
- Infographic: Why You Should Consider Syringe Service Programs
(Michigan Department of Health and Human Services, July 2018)
Testing and Reporting (including Evaluation Web)
HIV Case Reporting and Data Staff
HIV Case Reporting and Data team members are part of the Surveillance and Epidemiology Section within the MDHHS Division of HIV and STI Programs. They work out of two offices (Lansing and Southfield) and are divided into both geographical and type-specific coverage specialties.
- Staff Coverage Map and Contact Information (staff assignments by geographical area and type of coverage)
STI Case Reporting and Data Staff
The Disease Intervention Specialists (DIS) that oversee STI case reporting and data functions are part of the Field Services and STI Prevention Section within the MDHHS Division of HIV and STI Programs and are located throughout Michigan. Their responsibilities are divided by geographical coverage areas of the state.
- DIS Staff Coverage Map (staff assignments by geographical area of coverage)
(Please Note: Contact information for individual team members is available in the Directory of MDHHS HIV and STI Program Staffers on our Contact Us webpage.)
Health Care Professional's Guide to Disease Reporting in Michigan: A Summary of the Michigan Communicable Disease Rules
(Michigan Department of Health and Human Services, rev. January 2021)
The public health system depends upon reports of diseases and infections to monitor the health of the community and to provide the basis for preventive action. The prompt, required reporting by physicians, laboratory scientists, infection preventionists, and other care providers of both diagnosed and suspected communicable diseases/infections allows for timely action by local and state public health personnel.
Selecting Appropriate HIV Diagnostic Tests
(Michigan Department of Health and Human Services, July 2019)
Improved HIV detection tests offer the ability to detect HIV infection earlier and identify patients in the acute phase when high levels of virus increase the likelihood of transmitting infection. The recommendations in this guide allow for earlier detection of HIV and consequently, the increased possibility of reducing transmission.
Suggested Reporting Language for the HIV Laboratory Diagnostic Testing Algorithm
(Association of Public Health Laboratories, April 2017)
To maximize public health impact, accurate, timely diagnostic HIV testing should be combined with clear result reporting and expedited linkage to medical care and services for infected persons. Laboratory reports should state each test that was performed, the final assay result of each test, and the final algorithm interpretation for the specimen. The reporting language presented in this document is suggested for laboratories to use when reporting to healthcare providers and surveillance programs, but adjustments may be needed to meet individual facility or jurisdiction requirements.
Guidelines for Testing and Reporting: Perinatal Human Immunodeficiency Virus (HIV), Hepatitis B and Syphilis
(Michigan Department of Health and Human Services, rev. March 2020)
Physicians and other health care professionals providing medical treatment to pregnant women are required, at the time of initial prenatal screening and examination, to test for HIV, hepatitis B, and syphilis, unless the woman refuses to be tested or the provider deems the tests are medically inadvisable. (Per section 333.5123 of Michigan's Public Health Code, Act No. 368 of the Public Acts of 1978, as amended).
HIV Testing Guidance for Health and Life Insurance Companies Licensed in Michigan
(Michigan Department of Community Health, rev. May 2008)
This document provides information about the legal requirements that pertain to health and life insurance companies licensed in Michigan to underwrite testing for the presence of Human Immunodeficiency Virus (HIV).
False-Positive HIV Test Results fact sheet
(Centers for Disease Control and Prevention, May 2018)
When a person is not infected with HIV but receives a positive test result, that result is considered a false positive. False-positive test results can occur due to technical issues associated with the test or biological causes. Generally, HIV tests have high specificity, meaning that there are few false-positive results and testing correctly classifies most uninfected individuals as uninfected.
MC-234: Court Order for Counseling and Testing for Disease/Infection Under MCL 333.5129
(State Court Administrative Office, June 2019)
This form is used by the court under MCL 333.5129 to order confidential testing and counseling for venereal disease, hepatitis B and C infection, HIV infection, acquired immunodeficiency syndrome, and acquired immunodeficiency syndrome related complex.
- Instructions (rev. June 2019)
- DCH-1252: Verification Regarding Test Results Under MCL 333.5129 (Court-Ordered Testing) (rev. May 2005)
- Instructions (rev. October 2015)
- Instructions
- DCH-1253: Victim Authorization Regarding Notification of Test Results (rev. October 2004)
- Instructions (rev. March 2007)
- Instructions
- DCH-1221: Confidential Request for Local Health Department Assistance for Partner Services (rev. July 2015)
Healthcare providers can use this form to refer persons diagnosed as having HIV/AIDS or an at-risk sex/needle-sharing and/or cluster/network partner to a local health department for assistance with HIV Prevention Partner Services.- Instructions (rev. August 2015)
- Instructions
HIV Adult Case Reporting (for patients ≥ 13 years of age)
- DCH-1355: Michigan Adult HIV Confidential Case Report Form (rev. July 2021)
- Instructions (rev. July 2021)
- Examples of Reporting Various Diagnostic HIV Tests on DCH-1355 (rev. February 2016)
- How to Report Electronically in the Michigan Disease Surveillance System (MDSS) (rev. March 2018)
- Instructions
HIV Pediatric Case Reporting (for patients < 13 years of age)
- DCH-1402: Michigan Pediatric HIV/AIDS Confidential Case Report Form (rev. May 2020)
- Instructions (rev. May 2020)
- Instructions
STI Case Reporting
- Reporting STIs Electronically in the Michigan Disease Surveillance System (MDSS) (rev. February 2021)
- Disseminated Gonococcal Infection Case Report Form
Local health departments should complete this form when following up on a reported case of Disseminated Gonococcal Infection (DGI) in MDSS. Please update the form with available information from the provider and patient. Attach the completed form to the Patient 'Notes' tab in MDSS. Contact Jim Kent at kentj3@michigan.gov with questions about DGI and reporting.
Michigan HIV Evaluation Web is a cloud-based data system created by Luther Consulting under contract with the Centers for Disease Control and Prevention (CDC) to collect and house HIV prevention measures related to CDC funding opportunity announcement PS18-1802.
These measures include HIV test events entered at the individual tester level and aggregate data, such as the number of condoms distributed per month. Data are entered at the local level by funded local health departments and community benefit organizations. Data in Evaluation Web contain no personally identifiable information and are submitted directly to CDC through the system's web-based platform.
- Evaluation Web Log-In Portal
- Evaluation Web Local User Guide
(Michigan Department of Health and Human Services, April 2019)
Toolkits
MDHHS STI/HIV Billing Toolkit
(Michigan Department of Health and Human Services, February 2016)
Michigan-based STI/HIV clinics and organizations can use this toolkit to determine whether to bill; to set up and maintain a billing infrastructure; and to enhance the potential for revenue generation to sustain their services.
STI/HIV Billing Toolkit Appendices
- Appendix 1: Code Suppression List
- Appendix 2: Cost Benefit Analysis Tool
- Appendix 3: Medicaid Health Plan Key Contacts
- Appendix 4: Sample Superbill
- Appendix 5: Coding Guide
MDHHS PrEP Provider Toolkit
(Michigan Department of Health and Human Services, January 2017)
This toolkit for current or potential Pre-Exposure Prophylaxis (PrEP) providers explains how to properly administer PrEP. The resources in this toolkit are provided as helpful guides during the PrEP process and are meant to help provide the patient with the utmost care. The need for more physicians to begin prescribing PrEP is imminent, and this toolkit provides everything necessary to assist in the PrEP prescribing process.
MDHHS Social Media Toolkit
(Michigan Department of Health and Human Services, November 2015)
The idea for this toolkit arose as a result of a series of regional meetings and focus groups with HIV staff across the state of Michigan. Throughout those meetings, one of the recurring themes was a growing interest in using social media as a resource for HIV prevention work. We listened carefully, and this toolkit is the result of those conversations.
Undetectable Equals Untransmittable (U=U)
Based on the emerging research, the scientific consensus is that a person living with HIV who is taking antiretroviral therapy (ART) as prescribed and who has an undetectable viral load in their blood sample for at least six months has a negligible risk of transmitting HIV sexually.*
Viral load refers to the amount of HIV in a blood sample of a person living with HIV. Most often, the higher the viral load, the greater the likelihood an individual with HIV will transmit HIV. ART must be taken daily to achieve viral suppression and maintain untransmittable status.
- Undetectable = Untransmittable (U=U) website (Prevention Access Campaign)
- The Evidence for U=U (Undetectable = Untransmittable): Why Negligible Risk is Zero Risk (HIV i-Base/HIV Treatment Bulletin)
- Webinar: Demystifying U=U - Undetectable = Untransmittable (Michigan Department of Health and Human Services)
- Undetectable = Untransmittable (U=U) - Frequently Asked Questions (Michigan Department of Health and Human Services, rev. September 10, 2018)
- HIV Treatment as Prevention (Centers for Disease Control and Prevention)
*During 2016, two key studies (PARTNER and HPTN 052) were released showing that individuals living with HIV, who have undetectable viral loads, do not sexually transmit HIV to their HIV-negative partners.
Viral Hepatitis
Introduction to Hepatitis in Michigan
(Michigan Department of Health and Human Services)
Viral hepatitis is an infection that affects the liver. While there are at least five different types of hepatitis (A-E), the three most common types in the United States are hepatitis A, hepatitis B, and hepatitis C. Hepatitis A is an acute infection, and people usually improve without treatment. Hepatitis B and hepatitis C can cause chronic, persistent infections, which can lead to chronic liver disease. There are vaccines to prevent hepatitis A and hepatitis B; however, there is no vaccine for hepatitis C. This website from the MDHHS Viral Hepatitis Surveillance and Prevention Unit provides an overview of hepatitis types A, B and C and how Michigan is addressing them.
Data & Statistics About Hepatitis in Michigan
(Michigan Department of Health and Human Services)
This section of the MDHHS Viral Hepatitis website features summaries of hepatitis activities in Michigan and includes on hepatitis A, hepatitis B, perinatal hepatitis B, and hepatitis C in the state and includes issues of the Unit's quarterly newsletter and annual reports.
Syringe Services Program
(Michigan Department of Health and Human Services)
SSPs can also be known as Syringe Exchange Programs (SEP), Syringe Access Programs (SAP), and Needle Exchange Programs (NEP). They are a key component in a comprehensive harm reduction strategy.
These programs have been proven to reduce the harms of substance use to the individual and to the community. SSPs reconnect marginalized community members to their community and empower people to make positive changes in their lives. Syringe service programs focus on building relationships and provide people access to other vital services.
Michigan Hepatitis A Outbreak
(Michigan Department of Health and Human Services)
This section of the MDHHS Viral Hepatitis website provides information on the ongoing outbreak of hepatitis A in Michigan, including a summary of the current outbreak, an overview of the disease, methods to protect against infection, educational materials, and other resources.
